Regulator approves Itvisma for adults and children aged two and above, positioning the UAE among the first countries globally to authorise the treatment for a wider age group The post UAE expands access to gene therapy for spinal muscular atrophy patients appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More .